Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/07/2002US20020164712 Fusion protein for use in treatent of diabetes
11/07/2002US20020164711 Megakaryocyte differentiation factor
11/07/2002US20020164710 Platelet-derived growth factor D, DNA coding therefor, and uses thereof
11/07/2002US20020164709 Nucleotide sequences coding polypeptde for use in treatment and prevention of metabolic, immunological and nervous system disorder
11/07/2002US20020164708 Membrane proteins for use in the treatment of cancer and the prevention of metastasis
11/07/2002US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects
11/07/2002US20020164706 Regulating preferential gene expression; obtain cell, transform with expression vector, recover transformed cells, express genes, monitor expression of reporter molecules
11/07/2002US20020164705 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of inflammatory, cardiovascular and autoimmune disorders
11/07/2002US20020164704 Novel human monocyte chemotactic proprotein
11/07/2002US20020164703 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
11/07/2002US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
11/07/2002US20020164701 Polypeptide for use in the diagnosis and treatment of metabolic disorders
11/07/2002US20020164699 Nucleotide sequences coding polypeptide for use the treatment of hypercholesterolaemia, diabetes, hypercholesterolaemia, hypoglycemia, graves disease, goiter, cushing's, addison, gastrointestinal and autoimmune diseases
11/07/2002US20020164698 Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction
11/07/2002US20020164697 Nucleotide sequences coding polypeptides for use in treatment of autoimmune disease
11/07/2002US20020164695 Generating preferential polypeptides in yeast; obtain yeast, transform with vector containing antitripsin polypeptide, express vector, recover polypeptide
11/07/2002US20020164694 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infections
11/07/2002US20020164693 TM4SF receptor polynucleotides, polypeptides, and antibodies
11/07/2002US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies
11/07/2002US20020164691 Human vomeronasal receptor-5
11/07/2002US20020164690 Receptor based antagonists and methods of making and using
11/07/2002US20020164689 Nucleotide sequences codng polypeptide for use in the diagnosis and treatment of inflammation, autoimmune disease and sepsis
11/07/2002US20020164688 Membrane associated protein zupar1
11/07/2002US20020164687 Platelet-derived growth factor C, DNA coding therefor, and uses thereof
11/07/2002US20020164686 Molecules designated B7L-1
11/07/2002US20020164685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infectious diseases
11/07/2002US20020164684 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors, inflammation and shock
11/07/2002US20020164683 Human sel-10 polypeptides and polynucleotides that encode them
11/07/2002US20020164682 Mammalian cerberus-like protein and compositions
11/07/2002US20020164680 ErbB4 receptor-specific neuregulin related ligands and uses therefor
11/07/2002US20020164679 Polypeptides for use in the treatment of atherosclerosis and cardiovascular disorders
11/07/2002US20020164674 Expression vector for use as diagnostic tool in genetic engineering
11/07/2002US20020164669 Secreted protein HRGDF73
11/07/2002US20020164667 VEGFR-3 inhibitor materials and methods
11/07/2002US20020164666 Protein-protein interactions
11/07/2002US20020164665 Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof
11/07/2002US20020164664 Diagnosing prostate cancer in humans; obtain sample, incubate with binding agent, detect signal from bound agent, detection of signal indicates cancer
11/07/2002US20020164657 Detecting modulators of amyloid complex formation; obtain sample fluid containing aggregated amyloid peptide, incubate with modulator, monitor complex formation, adjustment in complex formation indicates modulator
11/07/2002US20020164655 Protein complex for use inthe diagnosis and treatment of nervous system disorders
11/07/2002US20020164650 Methods of assessing wolframin protein activity
11/07/2002US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002US20020164642 Pool of immunoglobulin polypeptides for use in treating and preventing, inflammation, allergies, cancer, bacterial or viral infection, diabetes, arthritis, myasthenia gravis and autoimmune diseases
11/07/2002US20020164641 Detecting modulators of tyrosine kinase activity; obtain expresion vector containg tyrosine kinase polypeptide, express vector, incubate with modulator, monitor adjustment activity or tyrosine kinase
11/07/2002US20020164640 MyD88 adapter-like proteins
11/07/2002US20020164637 Detecting receptor binding ligands; obtain cell extract, incubate with modulator, detect binding, monitor activity from receptor
11/07/2002US20020164627 Novel human transporter proteins and polynucleotides encoding the same
11/07/2002US20020164625 Compositions isolated from bovine tissues and methods for their use
11/07/2002US20020164624 VEGF-D expression in brain cancer
11/07/2002US20020164623 Diagnostic assay for antibiotic tolerance
11/07/2002US20020164617 Affinity selection-based screening of hydrophobic proteins
11/07/2002US20020164615 Protein complex for use in the dianosis and treatment of nervous system disorders, alzheimer's and non-insulin dependent diabetes mellitus
11/07/2002US20020164609 Mammalian cytokines; related reagents
11/07/2002US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002US20020164595 Sequence specific DNA binding by p53
11/07/2002US20020164585 Expression vector for use in the treatment of viral diseases
11/07/2002US20020164583 Targeting viral vectors to specific cells
11/07/2002US20020164582 Nucleotide sequences coding protein for use in the treatment of viral diseases
11/07/2002US20020164578 Nucleic acid molecules encoding glutx and uses thereof
11/07/2002US20020164576 Methods for diagnosis and treatment of diseases associated with altered expression of Nrf2
11/07/2002US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier
11/07/2002US20020164360 Topical applying peptide to skin
11/07/2002US20020164358 Culturing human cancer cells; purification, recovering of antigens
11/07/2002US20020164357 Lipopolysaccharides from gramnegative bacteria
11/07/2002US20020164356 Attenuated recombinant rabies virus mutants and live vaccines thereof
11/07/2002US20020164355 Test to detect antibodies; calibration
11/07/2002US20020164354 High molecular weight surface proteins of non-typeable haemphilus
11/07/2002US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002US20020164350 Chimeric papillomavirus-like particles
11/07/2002US20020164349 Induction apoptosis; west nile virus therapy
11/07/2002US20020164348 Inhibitors of viral infection
11/07/2002US20020164347 Neoglycoproteins
11/07/2002US20020164345 Compositions and methods for the therapy and diagnosis of colon cancer
11/07/2002US20020164344 Anticancer agents; vaccines
11/07/2002US20020164340 Multivalent MHC class II - peptide chimeras
11/07/2002US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002US20020164335 Compositions and methods for the study and diagnosis of prion diseases
11/07/2002US20020164334 Antibody-induced apoptosis
11/07/2002US20020164332 Mammalian cytokines; related reagents and methods
11/07/2002US20020164330 Novel molecules of the tango-77 related protein family and uses thereof
11/07/2002US20020164329 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides
11/07/2002US20020164325 Regeneration of axons; central nervous systewm disorders
11/07/2002US20020164318 Cell lines and vectors for stimulation of an immune response to a differentiation antigen stimulated by an altered antigen
11/07/2002US20020164311 Prevention of organ rejection
11/07/2002US20020164310 Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
11/07/2002US20020164305 Integrin fusion protein; binding to antibodies
11/07/2002US20020164304 Lung therapy
11/07/2002US20020164302 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
11/07/2002US20020164300 Interleukin-2 mutein expressed from mammalian cells
11/07/2002US20020162550 Sugarcane fractioning system
11/07/2002DE10121255A1 Use of alpha 1-antichymotrypsin polypeptide or nucleic acids encoding the polypeptide, or of a cell expressing the polypeptide, or of antibody against the polypeptide, for diagnosing, treating or preventing poorly-healing wounds
11/07/2002DE10120337A1 New nucleic acid encoding human receptor for steroid or sterol, useful for identifying modulators, for treating e.g. osteoporosis and prostatic hypertrophy
11/07/2002CA2453675A1 Genes and proteins for the biosynthesis of lactimidomycin
11/07/2002CA2449794A1 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity
11/07/2002CA2448607A1 Colloidal metal compositions and methods
11/07/2002CA2446408A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002CA2445974A1 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
1 ... 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 ... 2916